enmein

structure

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 10/15/2022 - "Natural products (NPs) are always the important sources in the field of drug discovery, among which spirolactone-type and enmein-type compounds exhibit a wide range of biological activities, especially anti-tumor activity. " 02/25/2018 - "Natural derived enmein-type diterpenoids exert cytotoxicity against a wide range of human cancer cells. " 10/15/2022 - "Spirolactone-type and enmein-type derivatives as potential anti-cancer agents derived from oridonin."
2.	Gliosis 11/30/2021 - "These results indicate that enmein not only inhibited glutamate release from cortical synaptosomes by suppressing Ca2+ influx and PKC but also increased KA-induced hippocampal neuronal death by suppressing gliosis and decreasing glutamate levels by increasing glutamate uptake."
3.	Carcinoma (Carcinomatosis) 06/01/1989 - "Among the three types, enmein-, oridonin-, and trichorabdal-type, of diterpenoids from Rabdosia trichocarpa, the latter showed the highest antitumor activity against Ehrlich ascites carcinoma in mice. "
4.	Brain Injuries (Brain Injury) 11/30/2021 - "Enmein Decreases Synaptic Glutamate Release and Protects against Kainic Acid-Induced Brain Injury in Rats."
5.	Ascites 06/01/1989 - "Among the three types, enmein-, oridonin-, and trichorabdal-type, of diterpenoids from Rabdosia trichocarpa, the latter showed the highest antitumor activity against Ehrlich ascites carcinoma in mice. "